|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
107,850,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
94,049 |
265,576 |
430,713 |
596,513 |
Total Sell Value |
$6,494,225 |
$18,639,582 |
$27,634,367 |
$32,139,570 |
Total People Sold |
5 |
7 |
7 |
9 |
Total Sell Transactions |
15 |
35 |
55 |
83 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lukatch Heath |
|
|
2024-01-29 |
4 |
OE |
$16.00 |
$64,000 |
D/D |
4,000 |
9,625 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-01-29 |
4 |
AS |
$66.03 |
$1,980,900 |
D/D |
(30,000) |
375,814 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-01-29 |
4 |
OE |
$1.79 |
$53,700 |
D/D |
30,000 |
405,814 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-01-23 |
4 |
AS |
$63.22 |
$958,783 |
D/D |
(15,000) |
375,814 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-01-23 |
4 |
OE |
$0.04 |
$21,600 |
D/D |
15,000 |
390,814 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-01-18 |
4 |
AS |
$60.28 |
$485,879 |
D/D |
(8,000) |
79,474 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-01-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2024-01-02 |
4 |
AS |
$62.91 |
$167,144 |
I/I |
(2,616) |
151,286 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2024-01-02 |
4 |
AS |
$62.91 |
$106,579 |
D/D |
(1,667) |
20,710 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2024-01-02 |
4 |
OE |
$21.41 |
$35,690 |
D/D |
1,667 |
22,377 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2024-01-02 |
4 |
AS |
$62.71 |
$191,741 |
D/D |
(3,000) |
175,935 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2024-01-02 |
4 |
OE |
$2.42 |
$7,260 |
D/D |
3,000 |
178,935 |
|
- |
|
Lukatch Heath |
Director |
|
2024-01-02 |
4 |
AS |
$62.85 |
$828,915 |
D/D |
(13,000) |
5,625 |
|
- |
|
Lukatch Heath |
Director |
|
2024-01-02 |
4 |
OE |
$16.00 |
$208,000 |
D/D |
13,000 |
18,625 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-12-26 |
4 |
AS |
$61.32 |
$925,538 |
D/D |
(15,000) |
375,814 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-12-26 |
4 |
OE |
$0.04 |
$400 |
D/D |
10,000 |
390,814 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-12-22 |
4 |
OE |
$2.03 |
$20,097 |
D/D |
9,900 |
380,814 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-12-18 |
4 |
AS |
$60.17 |
$481,417 |
D/D |
(8,000) |
79,474 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-12-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-12-14 |
4 |
AS |
$60.22 |
$843,080 |
D/D |
(14,000) |
79,474 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2023-12-14 |
4 |
OE |
$5.35 |
$74,900 |
D/D |
14,000 |
93,474 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-12-07 |
4 |
D |
$56.78 |
$18,454 |
D/D |
(325) |
20,710 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-12-07 |
4 |
AS |
$56.50 |
$565,000 |
D/D |
(10,000) |
21,035 |
|
- |
|
Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
|
2023-12-07 |
4 |
OE |
$21.41 |
$214,100 |
D/D |
10,000 |
31,035 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2023-12-01 |
4 |
AS |
$51.43 |
$136,442 |
I/I |
(2,618) |
152,594 |
|
- |
|
377 Records found
|
|
Page 4 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|